The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer

Cancer Biomarkers

Volumn 14, Issue 5, 2014, Pages 303-312

  Azab, Basem ^a   Mohammad, Farhan ^a   Shah, Neeraj ^a   Vonfrolio, Steven ^a   Lu, William ^a   Kedia, Shiksha ^a   Bloom, Scott W ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

Colorectal cancer; inflammation; neutrophil lymphocyte; NLR; platelets lymphocyte; PLR; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; LONG TERM SURVIVAL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEUTROPHIL LYMPHOCYTE RATIO; NORMAL VALUE; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; TREATMENT OUTCOME;

EID: 84964284804     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140416     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention. Basic Information About Colorectal Cancer. 2013 [cited 2013 April 16]; Available from: http://www.cdc.gov/cancer/colorectal/basic- info/index.htm.
2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357(9255): 539-45. Epub 2001/03/07.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860-7. Epub 2002/12/20.
4. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140(6): 883-99. Epub 2010/03/23.
5. Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, et al. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology. 2013; 84(2): 100-7. Epub 2012/11/14.
6. Sharma R, Zucknick M, London R, Kacevska M, Liddle C, Clarke SJ. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clinical colorectal cancer. 2008; 7(5): 331-7. Epub 2008/09/17.
7. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable col-orectal cancer. Biomarkers: Biochemical indicators of exposure, response, and susceptibility to chemicals. 2012; 17(3): 216-22. Epub 2012/03/20.
8. Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. British journal of cancer. 2011; 104(8): 1288-95. Epub 2011/03/31.
9. He W, Yin C, Guo G, Jiang C, Wang F, Qiu H, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013; 30(1): 439. Epub 2013/01/12.
10. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorec-tal cancer. Journal of surgical oncology. 2005; 91(3): 181-4. Epub 2005/08/25.
11. Hung HY, Chen JS, Yeh CY, Changchien CR, Tang R, Hsieh PS, et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. International journal of colorectal disease. 2011; 26(8): 1059-65. Epub 2011/04/12.
12. Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothe-lioma patients undergoing systemic therapy. Clinical cancer research: An official journal of the American Association for Cancer Research. 2010; 16(23): 5805-13. Epub 2010/10/20.
13. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Annals of surgical oncology. 2011; 18(12): 3362-9. Epub 2011/05/07.
14. Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B, et al. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Annals of surgical oncology. 2013; 20 Suppl 3: S650-60. Epub 2013/07/26.
15. Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. International journal of colorectal disease. 2010; 25(12): 1427-33. Epub 2010/09/08.
16. Kaneko M, Nozawa H, Sasaki K, Hongo K, Hiyoshi M, Tada N, et al. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy. Oncology. 2012; 82(5): 261-8. Epub 2012/04/28.
17. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vau-they JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Annals of surgical oncology. 2009; 16(3): 614-22. Epub 2009/01/09.
18. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemora-diation for locally advanced rectal cancer. Colorectal disease: The official journal of the Association of Coloproctol-ogy of Great Britain and Ireland. 2012; 14(10): e701-7. Epub 2012/06/27.
19. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011; 47(17): 2633-41. Epub 2011/07/05.
20. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. British journal of cancer. 2007; 97(9): 1266-70. Epub 2007/10/10.
21. Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JP, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. Journal of surgical oncology. 2008; 98(5): 371-6. Epub 2008/07/23.
22. Halazun KJ, Hardy MA, Rana AA, Woodland DCt, Luyten EJ, Mahadev S, et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Annals of surgery. 2009; 250(1): 141-51. Epub 2009/06/30.
23. Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg. 2011; 146(4): 471-8. Epub 2011/04/20.
24. Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, et al. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? International journal of colorectal disease. 2012; 27(10): 1347-57. Epub 2012/03/31.
25. Mallappa S, Sinha A, Gupta S, Chadwick S. Preoperative neu-trophil lymphocyte ratio greater than five is a prognostic factor for recurrent colorectal cancer. Colorectal disease: The official journal of the Association of Coloproctology of Great Britain and Ireland. 2012. Epub 2012/09/11.
26. Bain B, Seed M, Godsland I. Normal values for peripheral blood white cell counts in women of four different ethnic origins. Journal of clinical pathology. 1984; 37(2): 188-93. Epub 1984/02/01.
27. Sierko E, Wojtukiewicz MZ. Inhibition of platelet function: does it offer a chance of better cancer progression control? Seminars in thrombosis and hemostasis. 2007; 33(7): 712-21. Epub 2007/11/15.
28. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer cell. 2004; 6(5): 447-58. Epub 2004/11/16.
29. Pucci F, Pittet MJ. Molecular Pathways: Tumor-derived mi-crovesicles and their interactions with immune cells in vivo. Clinical cancer research: An official journal of the American Association for Cancer Research. 2013. Epub 2013/02/22.
30. Ferradini L, Miescher S, Stoeck M, Busson P, Barras C, Cerf-Bensussan N, et al. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyn-geal carcinoma. International journal of cancer Journal international du cancer. 1991; 47(3): 362-70. Epub 1991/02/01.
31. Hang ZB, Wei YQ, Wang YP, Xu NR. Direct ultrastructural evidence of lymphocyte-mediated cancer cell lysis in the microenvironment of Chinese nasopharyngeal carcinoma. Human pathology. 1991; 22(4): 320-5. Epub 1991/04/01.
32. Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Mey-erhardt JA, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. The Journal of pathology. 2010; 222(4): 350-66. Epub 2010/10/12.